Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 500 of 942 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/29/11
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 03/07/24
End: 11/30/26
Due: 11/30/27
Phase: N/A
Priority: Normal
Start: 04/12/19
End: 04/30/24
Due: 04/30/25
Phase: N/A
Priority: Normal
Start: 03/14/24
End: 03/14/29
Due: 03/14/30
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 06/30/10
Due: 06/30/11
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 04/19/24
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 07/15/19
End: 12/30/25
Due: 12/30/26
Phase: N/A
Priority: Normal
Start: 12/13/24
End: 12/02/25
Due: 12/02/26
Phase: N/A
Priority: Normal
Start: 10/18/11
End: 12/16/19
Due: 12/16/20
Phase: N/A
Priority: Normal
Start: 04/28/22
End: 05/09/23
Due: 05/09/24
Phase: N/A
Priority: Normal
Start: 01/04/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 08/30/18
End: 08/30/21
Due: 08/30/22
Phase: N/A
Priority: Normal
Start: 03/20/13
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 07/01/14
End: 04/01/16
Due: 04/01/17
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 03/01/26
Due: 03/01/27
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 01/31/23
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 04/15/19
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 05/31/12
Due: 05/31/13
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
Phase: N/A
Priority: Normal
Start: 03/01/24
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 09/30/17
Due: 09/30/18
Phase: N/A
Priority: Normal
Start: 11/20/18
End: 10/22/22
Due: 10/22/23